Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
21 October 2024
Sales revenues for September 2024
14 October 2024
Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOPHARMA" AD, by exercising warrants from the issue with ISIN BG9200001212
4 October 2024
Notification for initiation of acquisition transaction
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
30 October 2024
Individual financial statements for Q3 of 2024
20 November 2024
Financial revenues for January-October 2024

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A